46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
32.99.Z - Production of other products not classified elsewhere
46.49.Z - Wholesale trade of other household articles
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
72.11.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 6,1 | 1,5 | 2,9 | 90,5 |
EBITDA | 8,4 | -0,4 | -0 | 92 |
Short time liabilities | 13,7 | 23,2 | 19,7 | -15,1 |
Equity capital | 40 | 40,1 | 42,3 | 5,4 |
Operating profit (EBIT) | 6,2 | 1,7 | 2,1 | 18,4 |
Assets | 57,4 | 67 | 66,2 | -1,2 |
Net profit (loss) | 6,4 | 0,1 | 2,2 | 1945,6 |
Cash | 5,9 | 8,5 | 8,6 | 1,1 |
Net income from sale | 75 | 85,3 | 95,4 | 11,9 |
Liabilities and provisions for liabilities | 17,4 | 26,9 | 23,9 | -11,1 |
Working assets | 30,3 | 42,2 | 43,2 | 2,4 |
Depreciation | 2,1 | -2,2 | -2,1 | 2,7 |
% | % | % | p.p. | |
Profitability of capital | 16 | 0,3 | 5,2 | 4,9 |
Equity capital to total assets | 69,7 | 59,8 | 63,8 | 4 |
Gross profit margin | 8,1 | 1,8 | 3 | 1,2 |
EBITDA Margin | 11,2 | -0,5 | -0 | 0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 99 | 75 | -24 |
Current financial liquidity indicator | 2.1143457889556885 | 0,9 | ||
Net dept to EBITDA | -0.415920227766037 | 1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane